(Q36283496)

13 August 2017

1 reference

title

Innate immunity and atherogenesis (English)

1 reference

13 August 2017

M Rattazzi

1

1 reference

13 August 2017

E Faggin

series ordinal

2

1 reference

13 August 2017

B Bertipaglia

series ordinal

3

1 reference

13 August 2017

P Pauletto

series ordinal

4

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

14

1 reference

13 August 2017

issue

9

1 reference

13 August 2017

page(s)

747-751

1 reference

Inflammation in atherosclerosis

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Innate and adaptive immunity in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Immunomodulation for treatment and prevention of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Human C-reactive protein: expression, structure, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

C-reactive protein: risk marker or mediator in atherothrombosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Production of the long pentraxin PTX3 in advanced atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Interleukin 6 and haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2213OA

10.1191/0961203305LU2213OA

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference